May 1, 2021Open Access
A Cautionary Tale of Triple Therapy
Key Result
A 54-year-old man treated with triple antithrombotic therapy following PCI for STEMI developed hypotension, confusion, and hemiplegia before discharge.
Study Design
Type
Case Report (n=1)
Structured PICO
P
Population
A 54-year-old man with a history of atrial flutter who presented with anterior ST-segment elevation myocardial infarction complicated by cardiogenic shock.
I
Intervention
Percutaneous coronary intervention (PCI) of the left main coronary artery followed by triple antithrombotic therapy.
O
Outcome
Clinical course and development of complications.safety
This case highlights the severe risks, likely bleeding or hemorrhagic stroke, associated with triple antithrombotic therapy following PCI.
Abstract
A 54-year-old man with a history of atrial flutter presented with anterior ST-segment elevation myocardial infarction complicated by cardiogenic shock and underwent percutaneous coronary intervention of the left main coronary artery. He was placed on triple antithrombotic therapy and ultimately recovered. However, before discharge, he developed hypotension, confusion, and hemiplegia. (Level of Difficulty: Beginner.)
Cite This Study
Shahandeh et al. (Sat,) conducted a case report in ST-segment elevation myocardial infarction (n=1). Triple antithrombotic therapy was evaluated. A 54-year-old man treated with triple antithrombotic therapy following PCI for STEMI developed hypotension, confusion, and hemiplegia before discharge.